Skip to content

5-MeO-DMT: all studies

Page 70 of 110: studies 691 to 700 of 1,096, newest first. Back to the 5-MeO-DMT overview

Research

The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology

International Journal of Molecular Sciences January 10, 2023 Andrea Mastinu, Margrate Anyanwu, Marinella Carone et al. 45 citations

The need to identify effective therapies for the treatment of psychiatric disorders is a particularly important issue in modern societies. In addition, difficulties in finding new drugs have led pharmacologists to review and re-evaluate some past molecules, including psychedelics. For several years there has been growing interest among psychotherapists in psilocybin or lysergic acid...

Interaction of psychedelic tryptamine derivatives with a lipid bilayer

Chemistry and Physics of Lipids January 7, 2023 Fateme Zohairi, Himanshu Khandelia, Ali Asghar Hakami Zanjani 20 citations

Naturally occurring psychedelics have been used for a long time as remedies or in religious ceremonies and recreational activities. Recent studies have proven the therapeutic potential of some psychedelic compounds to safely treat a wide range of diseases such as anxiety, depression, migraine, and addiction. It is hypothesized that psychedelic compounds like tryptamines can exert their effects...

DOI: 10.1016/j.chemphyslip.2023.105279 (opens in new tab) Lipid bilayer Biophysics Biological membrane Tryptamines +1

Indolethylamine N-methyltransferase (INMT) is not essential for endogenous tryptamine-dependent methylation activity in rats.

Scientific Reports January 6, 2023 Nicolas G. Glynos, Lily Carter, Soo Jung Lee et al. 17 citations

Indolethylamine N-methyltransferase (INMT) is a transmethylation enzyme that utilizes the methyl donor S-adenosyl-L-methionine to transfer methyl groups to amino groups of small molecule acceptor compounds. INMT is best known for its role in the biosynthesis of N,N-Dimethyltryptamine (DMT), a psychedelic compound found in mammalian brain and other tissues. In mammals, biosynthesis of DMT is...

DOI: 10.1038/s41598-023-27538-y (opens in new tab) Full text (opens in new tab) Psychedelics Biochemistry Enzymes Brain chemistry

Pharmacokinetic and Pharmacodynamic Interaction of the Ayahuasca Constituents Harmine and Dimethyltryptamine (DMT) in the Rat Brain

January 4, 2023 Klemens Egger, Frederik Gudmundsen, Naja Støckel Jessen et al. preprint

RationaleThe psychedelic effects of the traditional Amazonian botanical decoction known as ayahuasca are attributed to the effects of N,N-dimethyltryptamine (DMT) at brain serotonin 5-HT2A receptors. To make oral DMT bioavailable, ayahuasca additionally contains reversible monoamine oxidase A (MAO-A) inhibitors, namely β-carboline alkaloids such as harmine. However, there is lacking biochemical...

DOI: 10.31219/osf.io/cv6ey (opens in new tab) Ayahuasca Harmine Pharmacology Harmaline +5

Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness

Journal of Psychopharmacology 2023 Matthias Forstmann, Christina Sagioglou, Alexander Irvine et al. 18 citations

Background: Past research reports a positive relationship between experience with classic serotonergic psychedelics and nature relatedness (NR). However, these studies typically do not distinguish between different psychedelic compounds, which have a unique psychopharmacology and may be used in specific contexts and with different intentions. Likewise, it is not clear whether these findings can...

Classic psychedelics do not affect T cell and monocyte immune responses.

Frontiers in Psychiatry 2023 Deborah Rudin, Alexander Areesanan, Matthias E. Liechti et al. 9 citations

Classic psychedelics have been shown to exert therapeutic potential for the treatment of various psychiatric disorders, neuropsychiatric diseases, and neuronal damage. Besides their psychopharmacological activity, psychedelics have been reported to modulate immune functions. There has thus far been a sparse exploration of the direct immune-modulating effect of psychedelics on human immune cells...

An encounter with the self: A thematic and content analysis of the DMT experience from a naturalistic field study.

Frontiers in Psychology 2023 Pascal Michael, David Luke, Oliver Robinson 16 citations

N,N-Dimethyltryptamine (DMT) is an endogenous serotonergic psychedelic capable of producing radical shifts in an experience that have significant implications for consciousness and its neural correlates, especially given the "disconnected consciousness" suggested by the "breakthrough" DMT state. Its increasing usage and clinical trial indicate the growing importance of a thorough elucidation of...

The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics

Therapeutic Advances in Psychopharmacology 2023 Ricarda Evens, Tomislav Majić, Timo Torsten Schmidt et al. 49 citations

Background: Classic serotonergic psychedelics have anecdotally been reported to show a characteristic pattern of subacute effects that persist after the acute effects of the substance have subsided. These transient effects, sometimes labeled as the ‘psychedelic afterglow’, have been suggested to be associated with enhanced effectiveness of psychotherapeutic interventions in the subacute period....

Therapeutic Effects of Ceremonial Ayahuasca Use for Methamphetamine Use Disorders and Other Mental Health Challenges: Case Studies in an Indigenous Community in Sonora, Mexico.

Journal of Psychoactive Drugs 2023 Anja Loizaga-Velder, Cecile Giovannetti, Ricardo Campoy Gomez et al. 9 citations

This paper describes three case studies from an outpatient intercultural therapeutic program founded and run by Yaqui health professionals and traditional healers to serve members of the Yaqui tribe residing in Sonora, Mexico. This pilot therapeutic program has been designed specifically for Indigenous individuals, incorporating the ceremonial use of naturally derived psychedelics in addressing...

A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine.

Frontiers in Pharmacology 2023 Klemens Egger, Frederik Gudmundsen, Naja Støckel Jessen et al. 17 citations

Rationale: The psychedelic effects of the traditional Amazonian botanical decoction known as ayahuasca are often attributed to agonism at brain serotonin 5-HT2A receptors by N,N-dimethyltryptamine (DMT). To reduce first pass metabolism of oral DMT, ayahuasca preparations additionally contain reversible monoamine oxidase A (MAO-A) inhibitors, namely β-carboline alkaloids such as harmine....